Diferencia entre revisiones de «Acanthosis nigricans»

Sin resumen de edición
 
(No se muestran 2 ediciones intermedias del mismo usuario)
Línea 1: Línea 1:
==Background==
==Background==
{{Skin anatomy background images}}
{{Skin anatomy background images}}
{{Primary derm lesions names}}
*Multiple forms, but malignant acanthosis nigricans is most important
*Multiple forms, but malignant acanthosis nigricans is most important
**Most commonly associated with [[colon cancer|colonic adenocarcinoma]], gastric cancer, ovarian cancer
**Most commonly associated with [[colon cancer|colonic adenocarcinoma]], gastric cancer, ovarian cancer
Línea 19: Línea 18:


==Evaluation==
==Evaluation==
===Workup===
===Diagnosis===
===Diagnosis===
*Red flags for ''malignant'' acanthosis nigricans:
*Red flags for ''malignant'' acanthosis nigricans:

Revisión actual - 16:14 11 dic 2024

Background

Normal dermal anatomy.
  • Multiple forms, but malignant acanthosis nigricans is most important
    • Most commonly associated with colonic adenocarcinoma, gastric cancer, ovarian cancer
    • Also associated with other dermal manifestations of internal cancers
  • Associated with GI and GU malignancies, which may have concomitant weight loss
  • Non malignant form may be associated with endocrine abnormalities, such as insulin resistance

Clinical Features

Malignant acanthosis nigricans secondary to ovarian cancer
  • Hyperpigmented, velvety
  • Plaques
  • Most commonly intertriginous areas, posterior neck
  • May have concurrent acrochordons, skin tags

Differential Diagnosis

Dark raised skin lesions

Evaluation

Workup

Diagnosis

  • Red flags for malignant acanthosis nigricans:
    • Oral involvement (up to 50%)
    • Rapid appearance of lesions
    • Extensive involvement
    • Older adult
    • Unexplained weight loss
    • Lesions in atypical sites such as palms/soles, mucous membranes

Management

Disposition

External Links

See Also

References


  • Schwarzenberger K, Callen JP. Chapter 53: Dermatologic manifestations in patients with systemic disease. In: Bolognia JL,‎ Schaffer JV,‎ Cerroni L, eds. Dermatology. 4th ed. Philadelphia, PA: Elsevier; 2017:820.